Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$155,246,781
+$29,573,882 QoQ
Shares Held
616,940
+6.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#188
of 4,176 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$32,466
PutShares
300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAI Capital Management holds $587,268,758 across 14 Drug Manufacturers - General names. ABBV ranks #1 (26.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
616,940 | $155,246,781 | |
| 2 | LLY |
ELI LILLY & Co
|
127,320 | $152,711,440 | |
| 3 | JNJ |
Johnson & Johnson
|
548,420 | $139,282,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
380,217 | $48,857,884 | |
| 5 | AMGN |
Amgen Inc
|
100,869 | $36,526,682 | |
| 6 | PFE |
Pfizer Inc
|
614,061 | $14,786,588 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
247,151 | $14,240,840 | |
| 8 | NVS |
Novartis AG
|
43,150 | $6,762,467 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,246,781 | 616,940 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $125,672,899 | 577,833 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $131,625,548 | 576,067 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $126,486,597 | 546,284 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $100,129,739 | 539,434 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $108,832,649 | 519,438 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $88,795,446 | 499,693 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $70,759,651 | 358,313 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $63,991,539 | 373,085 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $67,531,785 | 370,850 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $53,715,856 | 346,621 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $51,336,711 | 344,403 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,810,659 | 332,596 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $55,027,592 | 345,282 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $56,020,328 | 346,639 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $44,827,482 | 334,010 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $45,987,974 | 300,261 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $48,360,979 | 298,322 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $39,812,068 | 294,033 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $24,723,372 | 229,196 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $25,231,360 | 224,000 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $32,466 | 300 | Put | Sole | 2021-05-10 | |
| 2021-03-31 | $26,463,577 | 244,535 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $32,140,606 | 299,959 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $25,092,783 | 286,480 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $34,133,749 | 347,665 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $6,566,968 | 86,192 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||